Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-10-23 14:16:38 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: DOI: 10.1016/S0140-6736(21)01338-6
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0140673621013386
其他信息:
出版社: Elsevier BV
作者: Saad Z Usmani; Alfred L Garfall; Niels W C J van de Donk; Hareth Nahi; Jesus F San-Miguel; Albert Oriol; Laura Rosinol; Ajai Chari; Manisha Bhutani; Lionel Karlin; Lotfi Benboubker; Lixia Pei; Raluca Verona; Suzette Girgis; Tara Stephenson; Yusri Elsayed; Jeffrey Infante; Jenna D Goldberg; Arnob Banerjee; María-Victoria Mateos; Amrita Krishnan
